Akers N, Berry K, Taylor C
Clin Psychol Psychother. 2025; 32(2):e70049.
PMID: 40033558
PMC: 11876722.
DOI: 10.1002/cpp.70049.
Ruffalo M
Psychiatry Clin Psychopharmacol. 2024; 33(3):222-228.
PMID: 38765312
PMC: 11082629.
DOI: 10.5152/pcp.2023.23627.
Calciu C, Macpherson R, Chen S, Zlate M, King R, Rees K
Front Psychiatry. 2024; 15:1327783.
PMID: 38645417
PMC: 11026677.
DOI: 10.3389/fpsyt.2024.1327783.
Cugnetto M, Morris E, Bonfield S, Gates J, Morrison I, Newman E
JMIR Res Protoc. 2024; 13:e49849.
PMID: 38498035
PMC: 10985603.
DOI: 10.2196/49849.
Hudon A, Couture J, Dellazizzo L, Beaudoin M, Phraxayavong K, Potvin S
J Clin Med. 2023; 12(6).
PMID: 36983300
PMC: 10053204.
DOI: 10.3390/jcm12062299.
Talk-based approaches to support people who are distressed by their experience of hearing voices: A scoping review.
Burr C, Schnackenberg J, Weidner F
Front Psychiatry. 2022; 13:983999.
PMID: 36299547
PMC: 9589913.
DOI: 10.3389/fpsyt.2022.983999.
The Role of Cognitive Behavioral Therapy in the Management of Psychosis.
Agbor C, Kaur G, Soomro F, Eche V, Urhi A, Ayisire O
Cureus. 2022; 14(9):e28884.
PMID: 36225466
PMC: 9541382.
DOI: 10.7759/cureus.28884.
Further validation of the Cognitive Biases Questionnaire for psychosis.
Samson C, Achim A, Sicard V, Gilker A, Francoeur A, Franck N
BMC Psychiatry. 2022; 22(1):560.
PMID: 35986316
PMC: 9392283.
DOI: 10.1186/s12888-022-04203-8.
The Scope of Metacognitive Therapy in the Treatment of Psychiatric Disorders.
Sharma V, Sagar R, Kaloiya G, Mehta M
Cureus. 2022; 14(3):e23424.
PMID: 35475111
PMC: 9030663.
DOI: 10.7759/cureus.23424.
Dopaminergic dysfunction and excitatory/inhibitory imbalance in treatment-resistant schizophrenia and novel neuromodulatory treatment.
Wada M, Noda Y, Iwata Y, Tsugawa S, Yoshida K, Tani H
Mol Psychiatry. 2022; 27(7):2950-2967.
PMID: 35444257
DOI: 10.1038/s41380-022-01572-0.
Cannabis Use Among Patients With Psychotic Disorders.
Hirschtritt M, Young-Wolff K, Mathalon D, Satre D
Perm J. 2022; 25.
PMID: 35348056
PMC: 8817909.
DOI: 10.7812/TPP/20.179.
Efficacy and durability of cognitive behavior therapy in managing hallucination in patients with schizophrenia.
Shukla P, Padhi D, Sengar K, Singh A, Chaudhury S
Ind Psychiatry J. 2022; 30(2):255-264.
PMID: 35017809
PMC: 8709524.
DOI: 10.4103/ipj.ipj_94_20.
Paliperidone to Treat Psychotic Disorders.
Minwalla H, Wrzesinski P, Desforges A, Caskey J, Wagner B, Ingraffia P
Neurol Int. 2021; 13(3):343-358.
PMID: 34449689
PMC: 8396046.
DOI: 10.3390/neurolint13030035.
One-year randomized trial comparing virtual reality-assisted therapy to cognitive-behavioral therapy for patients with treatment-resistant schizophrenia.
Dellazizzo L, Potvin S, Phraxayavong K, Dumais A
NPJ Schizophr. 2021; 7(1):9.
PMID: 33580033
PMC: 7881089.
DOI: 10.1038/s41537-021-00139-2.
Progress in Schizophrenia Research and Treatment.
Focus (Am Psychiatr Publ). 2020; 18(4):440-442.
PMID: 33343257
PMC: 7725148.
DOI: 10.1176/appi.focus.18310.
Exploring the Benefits of Virtual Reality-Assisted Therapy Following Cognitive-Behavioral Therapy for Auditory Hallucinations in Patients with Treatment-Resistant Schizophrenia: A Proof of Concept.
Dellazizzo L, Potvin S, Phraxayavong K, Dumais A
J Clin Med. 2020; 9(10).
PMID: 33007909
PMC: 7601104.
DOI: 10.3390/jcm9103169.
The Clinical Effectiveness of Cognitive Behavioral Therapy for Patients with Insomnia and Depression: A Systematic Review and Meta-Analysis.
Feng G, Han M, Li X, Geng L, Miao Y
Evid Based Complement Alternat Med. 2020; 2020:8071821.
PMID: 32733587
PMC: 7378630.
DOI: 10.1155/2020/8071821.
Mindfulness-Based Interventions for People with Schizophrenia: A Systematic Review and Meta-Analysis.
Hodann-Caudevilla R, Diaz-Silveira C, Burgos-Julian F, Santed M
Int J Environ Res Public Health. 2020; 17(13).
PMID: 32629764
PMC: 7369977.
DOI: 10.3390/ijerph17134690.
Targets and outcomes of psychotherapies for mental disorders: an overview.
Cuijpers P
World Psychiatry. 2019; 18(3):276-285.
PMID: 31496102
PMC: 6732705.
DOI: 10.1002/wps.20661.
Psychological interventions for people with psychotic experiences: protocol for a systematic review and meta-analysis.
Soneson E, Russo D, Knight C, Lafortune L, Heslin M, Stochl J
Syst Rev. 2019; 8(1):124.
PMID: 31122287
PMC: 6533690.
DOI: 10.1186/s13643-019-1041-5.